PART B - Clinical Sciences
All taught modules are compulsory. For Cancer Treatments 1 and 2, you will attend lectures on all topics listed, but will then choose to submit your assessments on one topic from the respective module (and at least one assessment must be related to a core topic).
4. Research Methods (10 credits)
This module is designed to give you a fundamental appreciation of the principles of clinical research and the ethics involved in running trials.
You will also be taught about trial design and the appropriate endpoints to choose, as well as developing the skills to interpret results gained in clinical trials, how to write them up into a paper, and how to consider and understand their implications for clinical practice.
5. Cancer Treatments 1 (20 credits)
This module, like its sister module Cancer Treatments 2, is about developing knowledge and critical understanding of a range of common and rarer malignancy types and tumour sites to aid you in your clinical management of cancer.
Core topics:
- Principles of Genito-Urinary Cancers
- Principles of Gastro-Intestinal Cancers
- Gynaecological Malignancy
Specialist topics:
- Acute Oncology
- Palliative Care
- Sarcoma
- Skin Malignancy
- HIV Related Malignancy
- Living with and Beyond Cancer/Survivorship
6. Cancer in Context (10 credits)
This module considers people with cancer, both individually as they experience the disease as well as in a wider social context.
You will consider topics such as the mainstream concepts and practice in cancer care, including ethical and communication issues which may arise.
7. Cancer Treatments 2 (20 credits)
This module, like its sister module Cancer Treatments 1, is about developing knowledge and critical understanding of a range of common and rarer malignancy types and tumour sites to aid you in your clinical management of cancer.
Core topics
- Breast Cancer
- Respiratory and Lung Cancer
- Head and Neck Cancer
Specialist topics
- Central Nervous System Cancer
- Lymphoma / Haematological Cancer
- Cancer Control in Low and Middle Income Countries
- Paediatric/Teenage/Young Adult Cancer